Integrated Core Strategies (US) LLC 13D and 13G filings for Abeona Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2024-10-08 4:29 pm Purchase |
2024-09-30 | 13G | Abeona Therapeutics Inc. ABEO |
Integrated Core Strategies (US) LLC | 2,301,628 5.300% |
882,953![]() (+62.24%) |
Filing |
2024-01-10 4:22 pm Purchase |
2023-12-31 | 13G | Abeona Therapeutics Inc. ABEO |
Integrated Core Strategies (US) LLC | 1,418,675 5.700% |
56,576![]() (+4.15%) |
Filing |
2023-12-04 4:09 pm Purchase |
2023-11-27 | 13G | Abeona Therapeutics Inc. ABEO |
Integrated Core Strategies (US) LLC | 1,362,099 5.500% |
1,362,099![]() (New Position) |
Filing |